UWWC1-DS2U

** The karyotype for this cell line may contain a non-clonal finding known to be recurrent in pluripotent stem cells. Please see the karyotype report in the currently distributing lot(s) ``Product Information & Testing`` PDF(s) linked below for more information.

This cell line is a modified version of a trisomy 21 (Ts21) human fibroblast line engineered to remove the third copy of human chromosome 21 (HSA21). This isogenic control is unaffected.
Cell Line Alias DS2U
Cell Type Modified Human iPS
Disease None reported
Genetic Modification Keyword Isogenic; Down syndrome, Trisomy 21
Sex Male
Age at Collection 1 Years
Genetically Related Cell Lines  
Reprogramming Method Viral transfection (Lentivirus: Oct4, Klf4, Sox2, cMyc)
Provider University of Wisconsin - Dr. Anita Bhattacharyya
dbGaP Data  
hPSCReg ID  
NIH Approval  
Pub Med Abstract  
Related Products
Collection(s) Down syndrome (Bhattacharyya) Collection
Have you received this cell line previously? Yes No Why we ask
Quantity: Learn about our volume discounts

Current Lot Information

Lot Number Culture Platform Lot Description Passage Number Banked By Protocol Product Information & Testing
WB67907 mTeSR Plus/Matrigel   55 WiCell WiCell Feeder Independent Pluripotent Stem Cell Protocol PDF

Historical Lot Information

Lot Number Culture Platform Lot Description Banked By Protocol Product Information & Testing
WB17714 mTeSR1/Matrigel   WiCell WiCell Feeder Independent Pluripotent Stem Cell Protocol PDF
WB19012 mTeSR1/Matrigel   WiCell WiCell Feeder Independent Pluripotent Stem Cell Protocol PDF